Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hellman

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Scientific Reports|November 24, 2021
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestineElham Barazeghi, Per Hellman, Olov Norlén, et al.
World Journal of Surgery|October 19, 2004
Long-term survival of patients with small intestinal carcinoid tumorsNiklas Zar, Hans Garmo, Lars Holmberg, et al.
World Journal of Surgery|February 5, 2010
Prophylactic cholecystectomy in midgut carcinoid patientsOlov Norlén, Ola Hessman, Peter Stålberg, et al.
Scientific Reports|June 7, 2018
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survivalRajani Maharjan, Samuel Backman, Tobias Åkerström, et al.
Surgery|March 15, 2002
Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuric hypercalcemiaEva Szabo, Per Hellman, Ewa Lundgren, et al.
Lakartidningen|March 8, 2002
[A case report. FDG-PET in occult breast cancer]Sam Ladjevardi, Jens Sörensen, Per Hellman, et al.
Cancers|June 29, 2019
<sup>11</sup>C-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and ParagangliomaAchyut Ram Vyakaranam, Joakim Crona, Olov Norlén, et al.
BJS Open|May 31, 2022
Preoperative prophylactic active vitamin D to streamline total thyroidectomyMatilda Annebäck, Edward McHale Sjödin, Per Hellman, et al.
European Journal of Endocrinology|October 29, 2019
Whole genome sequencing of apparently mutation-negative MEN1 patientsSamuel Backman, Duska Bajic, Joakim Crona, et al.
Nuclear Medicine and Biology|March 3, 2012
11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastasesOlov Norlén, Anders Nilsson, Johan Krause, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Scientific Reports|November 24, 2021
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestineElham Barazeghi, Per Hellman, Olov Norlén, et al.
World Journal of Surgery|October 19, 2004
Long-term survival of patients with small intestinal carcinoid tumorsNiklas Zar, Hans Garmo, Lars Holmberg, et al.
World Journal of Surgery|February 5, 2010
Prophylactic cholecystectomy in midgut carcinoid patientsOlov Norlén, Ola Hessman, Peter Stålberg, et al.
Scientific Reports|June 7, 2018
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survivalRajani Maharjan, Samuel Backman, Tobias Åkerström, et al.
Surgery|March 15, 2002
Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuric hypercalcemiaEva Szabo, Per Hellman, Ewa Lundgren, et al.
Lakartidningen|March 8, 2002
[A case report. FDG-PET in occult breast cancer]Sam Ladjevardi, Jens Sörensen, Per Hellman, et al.
Cancers|June 29, 2019
<sup>11</sup>C-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and ParagangliomaAchyut Ram Vyakaranam, Joakim Crona, Olov Norlén, et al.
BJS Open|May 31, 2022
Preoperative prophylactic active vitamin D to streamline total thyroidectomyMatilda Annebäck, Edward McHale Sjödin, Per Hellman, et al.
European Journal of Endocrinology|October 29, 2019
Whole genome sequencing of apparently mutation-negative MEN1 patientsSamuel Backman, Duska Bajic, Joakim Crona, et al.
Nuclear Medicine and Biology|March 3, 2012
11C-5-hydroxytryptophan positron emission tomography after radiofrequency ablation of neuroendocrine tumor liver metastasesOlov Norlén, Anders Nilsson, Johan Krause, et al.
Pageof 14